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A 25-year-old primigravida with Marfan syndrome (MFS) was admitted at 36 weeks of gestation (WOG). 
History 
The patient was diagnosed with MFS at puberty and the syndrome was confirmed genetically. At the age of 20 she 
suffered from pneumothorax which was treated with thoracoscopic drainage. At the time of the patient’s admission to 
our clinic, we specifically asked whether there had been any occurrence of cardiovascular-related symptoms prior to her 
pregnancy, and the patient denied there had been any such symptoms. A cervical pessary was used between the 24th and 
32nd WOG. Intravenous tocolytic therapy for prolonging gestation and intramuscular corticosteroids for accelerating fetal 
lung maturation were both administered in the 32nd WOG due to significant risk of a preterm birth. In the 2nd trimester 
of pregnancy, transthoracic echocardiogram (TTE) testing revealed an increased aortic maximal root dimension compared 
with the before-pregnancy TTE value (40 vs 44 mm); and we observed no pathological changes in other echocardiographic 
parameters. During hospitalization at the 34th WOG, ECG results were normal and the TTE results were: maximal aortic root 
dimension = 46 mm, and ascending aorta dimension = 33 mm. The patient’s sister was also diagnosed with MFS and suffered 
from aortic valve disease which had required surgical replacement. 
On physical examination 
The patient had an above-average height (193 cm), long limbs, arachnodactyly, a regular cardiac function, 80 BPM with 
auscultatory events properly accentuated, BP = 80/50, symmetrical radial pulse, meagre varicose veins on her lower extremi-
ties, and a shortened 1-centimeter dilated cervix. 
Cardiac assessment 
ECG results were normal (sinus rhythm, 80 bpm). No signs of progression were observed in TTE values (maximal 
aortic root dimension: 46 mm (Fig. 1), and ascending aorta dimension: 32 mm). Due to Marfan syndrome being compli-
Figure 2 Parasternal long axis view — aorta root echocardiographic 
assessment after delivery
Figure 1 Parasternal long axis view — aorta root echocardiographic 
assessment prior to delivery
717
Maciej Osinski et al., Perinatal and cardiovascular outcomes in a pregnant patient with Marfan syndrome
www. journals.viamedica.pl/ginekologia_polska
cated by little-altered maximal aorta root and ascending aorta dimensions after observation, we performed an elective 
caesarean delivery at term (newborn: healthy daughter, 3300 g, Ap 10, 10). During the early puerperium period, the 
patient did not report any cardiovascular-related symptoms and TTE results did not significantly differ from the last as-
sessment made during the pregnancy (Fig. 2). During the puerperium period, low molecular weight heparin was used 
as a thromboprophylaxis, and 4 days after caesarean delivery the patient was discharged from hospital in good health. 
Marfan syndrome remains the dominant autosomal genetic disease that affects connective tissue. The cardiovas-
cular system, the skeleton and organs such as the pleura are all affected and therefore pneumothorax may occur. MFS 
prevalence is estimated at 1:5.000–1:6.500. Aortic dissection remains the major cause of mortality and morbidity in MFS 
patients, determined at 1.2% and 7.9%, respectively. In the course of pregnancy, the risk of aortic dissection rises; and 
Tsuritani et al also described two such patients in their study. We conclude that it is important, when caring for women 
with MFS, to obtain a diagnosis prior to pregnancy. In cases of women not being diagnosed prior to pregnancy, the 
risk of life-threatening MFS complications during pregnancy, delivery or the puerperium period increases. Therefore, 
pregnancy in MFS women should be planned, and it is crucial to conduct careful echocardiographic assessments prior 
to pregnancy. For women with aortic diameters of  ≥ 40 mm, prophylactic aortic surgery is advised prior to pregnancy. 
However, the European Society of Cardiology (ESC) recommends surgery should always be performed prior to pregnancy 
in cases of a root aorta diameter of > 45 mm. The association between MFS and risk of premature labour and delivery is 
well documented; and this was also demonstrated in our case.
